Study of COVID treatment Quellor has first patient at Louisville hospital
Tranquil is proud to announce the success of our strategic research site partner, the cardiology research team at Jewish Hospital in Louisville, KY! Dr. Naresh Solankhi & his...
INmune Bio, Inc. Announces First Patient Dosed in Phase 2 Trial of Quellor™ for Pulmonary Complications in COVID-19 Patients
Congratulations to INmune Bio! Tranquil is proud to be a part of this tremendous effort on enrolling the first patient to this important study. LA JOLLA, Calif, Nov....
Quickest Site Activation
Tranquil Clinical Research was the fastest site activated and quickest site to enroll on a Pivotal COVID clinical trial for a top 20 Pharmaceutical Sponsor.
Remote Study Start-up Whitepaper
Worried about your research program stalling due to Covid-19? Tranquil Clinical Research has the solution for safely and successfully starting up your trial during a pandemic. The FDA’s...
Tranquil Clinical Research Training Mantra
Improving Clinical Trials by improving the people who work on them. A company may have the most state-of-the-art systems, the best leadership, layers of management but the folks...
Work – Life Balance – Tranquil Style
What does work life balance really mean? At Tranquil Clinical Research we want our employees to know we appreciate them and that means giving them time to do...